Thozhukat Sathyapalan is a professor at the
Hull York Medical School at the University of Hull. He obtained his undergraduate
degree in Medicine from the University of Kerala, India, in 1996 and his MD
(general medicine) from JIPMER, India. He subsequently completed his clinical
training in Diabetes and Endocrinology as a Specialist Registrar in Yorkshire
Deanery. Sathya was a Clinical Research Fellow at the University of Hull and
obtained his MD (diabetes and endocrinology) in 2009. He was appointed as
Senior Lecturer at Hull York Medical School in October 2009, Reader in 2012, and
was made Chair in Academic Endocrinology and Metabolism in 2016. His main area of interest is the modulation of cardiovascular risk
through pharmacological and nutritional interventions in insulin-resistant
states, such as obesity, polycystic ovary syndrome (PCOS), and type 2 diabetes
mellitus.
Timothy Palmer is a professor at the Hull
York Medical School at the University of Hull. He completed his Ph.D. in
Molecular Pharmacology at the University of Glasgow. He carried out
postdoctoral training as an American Heart Association Research Fellow in the
Cardiology Division at Duke University Medical Centre, North Carolina, USA. He
returned to the UK in 1997 as a Lecturer in Biochemistry at the University of
Glasgow and developed an externally funded research program focusing on
cardiovascular cell signalling and disease. From 2015, he was Professor of
Pharmacology and Head of Pharmacology and Experimental Therapeutics at the
School of Pharmacy and Medical Sciences at the University of Bradford before
being recruited to a Chair in Cardiovascular Biology at Hull York Medical
School in 2018. He was awarded the American Heart Association Basic Science
Research Fellowship in 1996–1997. His interests include identifying the
molecular mechanisms responsible for cardiovascular disease.
